Clinuvel Pharmaceuticals Limited (CLVLF)
| Previous Close | 8.38 |
| Open | 8.38 |
| Bid | 7.99 x 39400 |
| Ask | 8.99 x 34100 |
| Day's Range | 8.38 - 8.38 |
| 52 Week Range | 8.38 - 11.55 |
| Volume | |
| Avg. Volume | 150 |
| Market Cap | 424.928M |
| Beta (5Y Monthly) | 0.85 |
| PE Ratio (TTM) | 18.62 |
| EPS (TTM) | 0.45 |
| Earnings Date | Feb 20, 2025 - Feb 24, 2025 |
| Forward Dividend & Yield | 0.03 (0.41%) |
| Ex-Dividend Date | Sep 05, 2024 |
| 1y Target Est | N/A |
Simply Wall St.Three High Growth Tech Stocks in Australia
As the Australian market experiences a modest uptick with the ASX200 rising around 1% to 8,210 points, investors are closely monitoring the ongoing US election and its potential impact on global markets. In this environment of cautious optimism, identifying high growth tech stocks requires careful consideration of factors such as innovation potential, market positioning, and adaptability in dynamic sectors like technology.
Simply Wall St.ASX Growth Leaders Featuring Clinuvel Pharmaceuticals And 2 Insider-Favored Stocks
As the Australian market holds steady with investors eyeing key inflation data and recent movements in major indices, the focus turns to growth companies showing resilience amidst economic fluctuations. In this environment, stocks with high insider ownership can be particularly appealing as they often indicate confidence from those closest to the company's operations.
